[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ocular Therapeut (OCUL)

Ocular Therapeut (OCUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,788,903
  • Shares Outstanding, K 218,960
  • Annual Sales, $ 51,950 K
  • Annual Income, $ -265,940 K
  • EBIT $ -299 M
  • EBITDA $ -295 M
  • 60-Month Beta 0.88
  • Price/Sales 35.70
  • Price/Cash Flow N/A
  • Price/Book 3.19

Options Overview Details

View History
  • Implied Volatility 104.03% (+3.67%)
  • Historical Volatility 47.35%
  • IV Percentile 72%
  • IV Rank 18.30%
  • IV High 363.10% on 02/13/26
  • IV Low 46.01% on 08/22/25
  • Expected Move (DTE 6) 0.65 (8.01%)
  • Put/Call Vol Ratio 0.04
  • Today's Volume 2,586
  • Volume Avg (30-Day) 2,364
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 41,506
  • Open Int (30-Day) 44,004
  • Expected Range 7.52 to 8.82

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.40
  • Number of Estimates 5
  • High Estimate $-0.36
  • Low Estimate $-0.42
  • Prior Year $-0.39
  • Growth Rate Est. (year over year) -2.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.15 +0.25%
on 07/31/26
10.94 -25.32%
on 07/09/26
-1.65 (-16.80%)
since 06/30/26
3-Month
7.86 +3.94%
on 05/21/26
10.94 -25.32%
on 07/09/26
-1.20 (-12.81%)
since 04/30/26
52-Week
6.23 +31.14%
on 02/17/26
16.44 -50.30%
on 12/08/25
-3.49 (-29.93%)
since 07/30/25

Most Recent Stories

More News
3 Russell 2000 Stocks That Concern Us

3 Russell 2000 Stocks That Concern Us

TFIN : 75.93 (+2.84%)
BKU : 46.65 (+1.24%)
OCUL : 8.17 (-3.54%)
Pharmaceuticals Stocks Q1 In Review: Ocular Therapeutix (NASDAQ:OCUL) Vs Peers

Pharmaceuticals Stocks Q1 In Review: Ocular Therapeutix (NASDAQ:OCUL) Vs Peers

OCUL : 8.17 (-3.54%)
3 Cash-Burning Stocks with Open Questions

3 Cash-Burning Stocks with Open Questions

MSTR : 93.28 (-4.56%)
RDNT : 63.78 (+1.74%)
OCUL : 8.17 (-3.54%)
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., July 09, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina...

OCUL : 8.17 (-3.54%)
3 Small-Cap Stocks with Open Questions

3 Small-Cap Stocks with Open Questions

BCC : 76.38 (+1.33%)
TLYS : 3.81 (+2.70%)
OCUL : 8.17 (-3.54%)
Ocular Therapeutix™ to Participate in July Scientific and Investor Conferences

BEDFORD, Mass., July 01, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced...

OCUL : 8.17 (-3.54%)
Ocular Therapeutix (OCUL): Buy, Sell, or Hold Post Q1 Earnings?

Ocular Therapeutix (OCUL): Buy, Sell, or Hold Post Q1 Earnings?

OCUL : 8.17 (-3.54%)
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., June 22, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina...

OCUL : 8.17 (-3.54%)
Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos

Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos

MDLZ : 62.31 (-1.22%)
NU : 14.33 (-1.10%)
RMD : 210.98 (+1.16%)
SONO : 14.66 (+1.59%)
OCUL : 8.17 (-3.54%)
Why Ocular Therapeutix (OCUL) Stock Is Up Today

Why Ocular Therapeutix (OCUL) Stock Is Up Today

OCUL : 8.17 (-3.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ocular Therapeutix, Inc. is a biopharmaceutical company. It is focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. The Company develops and markets eye care products. Ocular...

See More

Key Turning Points

3rd Resistance Point 8.85
2nd Resistance Point 8.71
1st Resistance Point 8.44
Last Price 8.17
1st Support Level 8.03
2nd Support Level 7.88
3rd Support Level 7.61

See More

52-Week High 16.44
Fibonacci 61.8% 12.54
Fibonacci 50% 11.34
Fibonacci 38.2% 10.13
Last Price 8.17
52-Week Low 6.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.